Carregant...
A pathologist’s perspective on induced pluripotent stem cells
Induced pluripotent stem cell (iPSC) technology was originally developed in 2006. Essentially, it converts somatic cells into pluripotent stem cells by transiently expressing a few transcriptional factors. Once generated, these iPSCs can differentiate into all the cell types of our body, theoretical...
Guardat en:
| Publicat a: | Lab Invest |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5918271/ https://ncbi.nlm.nih.gov/pubmed/28759008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/labinvest.2017.81 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|